I-Pfizer ikhumbula ama-capsules e-Inderal-LA (propranolol hydrochloride).

Imikhiqizo: Inderal-LA (propranolol hydrochloride) amaphilisi okukhululwa enwetshiwe, ku-60 mg, 80 mg, 120 mg kanye no-160 mg amandla

• Inkinga: Yonke le mikhiqizo eminingi iyabuyiselwa ngenxa yokuba khona kokungcola kwe-nitrosamine ngaphezu kwezinga elamukelekayo.

• Okufanele ukwenze: Xhumana nomhlinzeki wakho wezempilo ukuze nixoxe ngezinye izindlela zokwelashwa. Nakuba zingekho ezinye izinkampani ezikhangisa ukukhululwa okunwetshiwe kwe-propranolol e-Canada, imikhiqizo ye-propranolol ekhishwa ngokushesha iyaqhubeka nokutholakala, kanye nezinye izinketho zokwelapha. Qhubeka uphuza imithi yakho ngaphandle uma uceliwe ukuthi uyeke umhlinzeki wakho wezempilo. Ukungaselaphi isimo sakho kubeka engcupheni enkulu yezempilo.

Issue

I-Pfizer Canada ULC ikhumbula wonke amaphilisi amaningi e-Inderal-LA (propranolol hydrochloride) enwetshiwe yokukhululwa, ku-60 mg, 80 mg, 120 mg kanye namandla angu-160 mg, ngenxa yokuba khona kokungcola kwe-nitrosamine (N-nitroso-propranolol) ngaphezu izinga elamukelekayo.

I-Ideral-LA umuthi kadokotela owaziwa ngokuthi i-beta-blocker. Isetshenziswa kubantu abadala ukwelapha umfutho wegazi ophakeme futhi ivimbele i-angina pectoris (isimo esihambisana nobuhlungu besifuba obubukhali kanye nokuphefumula kanzima, okuvame ukuhlotshaniswa nokuzivocavoca).

Ukuchayeka isikhathi eside ku-N-nitroso-propranolol ezingeni elingaphezu kwalokho okubhekwa njengokuphephile kungase kwenyuse ingozi yomdlavuza. Sonke sichayeka emazingeni aphansi e-nitrosamine ngokudla okunhlobonhlobo (njengenyama ebhenywayo nelashiwe, imikhiqizo yobisi, nemifino), amanzi okuphuza, kanye nokungcoliswa komoya. Lokhu kungcola akulindelekile ukuthi kubangele ukulimala lapho kudliwe ezingeni elivumelekile noma ngaphansi. Umuntu odla isidakamizwa esiqukethe lokhu kungcola ezingeni elamukelekayo noma elingaphansi kwazo zonke izinsuku iminyaka engu-70 akulindelekile ukuthi abe sengozini enkulu yokuba nomdlavuza.

Njengokukhumbula kwangaphambilini okubandakanya ukungcola kwe-nitrosamine, i-Health Canada yeluleka ukuthi ayikho ingozi esheshayo yokuqhubeka nokuthatha imithi ekhunjulwayo ye-Ideral-LA njengoba ingozi engaba khona yomdlavuza ihambisana nokuchayeka isikhathi eside (nsuku zonke iminyaka engu-70) ku-nitrosamine. ukungcola ngaphezu kwezinga elamukelekayo. Iziguli zingaqhubeka nokuphuza imithi yazo njengoba ziyalelwe umhlinzeki wazo wezempilo futhi akudingekile ukuba zibuyisele imithi yazo ekhemisi, kodwa kufanele zithinte umhlinzeki wazo wezempilo ukuze baxoxe ngezinye izindlela zokwelapha. Nakuba zingekho ezinye izinkampani ezikhangisa ukukhululwa okunwetshiwe kwe-propranolol e-Canada, i-propranolol ekhishwa ngokushesha iyaqhubeka nokutholakala kanye nezinye izinketho zokwelapha/imithi ye-beta blocker.

I-Health Canada iqapha ukusebenza kahle kokukhumbula kanye nokusebenzisa kwenkampani noma yiziphi izinyathelo ezidingekayo zokulungisa nokuvimbela. Uma kwenzeka noma yikuphi ukukhumbula okwengeziwe kudingekile, i-Health Canada izobuyekeza ithebula futhi yazise abantu baseCanada.

Imikhiqizo ethintekile

Ukuphelelwa yisikhathi kwe-DIN yomkhiqizo

Inderal-LA 60 mg 02042231 EX7461 2024-01-31

Inderal-LA 60 mg 02042231 EH5907 2023-08-31

Inderal-LA 60 mg 02042231 DX6150 2023-03-31

Inderal-LA 80 mg 02042258 EX7462 2024-01-31

Inderal-LA 80 mg 02042258 EL1695 2023-08-31

Inderal-LA 80 mg 02042258 EE7221 2023-05-31

Inderal-LA 80 mg 02042258 DW8242 2023-03-31

Inderal-LA 80 mg 02042258 DJ2768 2022-09-30

Inderal-LA 120 mg 02042266 FE0541 2024-01-31

Inderal-LA 120 mg 02042266 EH5908 2023-08-31

Inderal-LA 120 mg 02042266 DX6159 2023-03-31

Inderal-LA 120 mg 02042266 DJ6820 2022-09-30

Inderal-LA 160 mg 02042274 FE6304 2024-01-31

Inderal-LA 160 mg 02042274 EH5906 2023-08-31

Inderal-LA 160 mg 02042274 DW8241 2023-03-31

Okufanele ukwenze

• Xhumana nomhlinzeki wakho wokunakekelwa kwezempilo ukuze nixoxe ngezinye izindlela zokwelapha, njengoba zingekho ezinye izinkampani ezikhangisa ukukhishwa okunwetshiwe kwe-propranolol e-Canada.

• Qhubeka uphuza imithi yakho ngaphandle uma uceliwe ukuthi uyeke umhlinzeki wakho wezempilo. Ukungaselaphi isimo sakho kubeka engcupheni enkulu yezempilo.

• Xhumana ne-Pfizer Canada ULC ku-1-800-463-6001 noma ku-www.pfizermedinfo.ca ngemibuzo yezokwelapha naku-1-800-387-4974 ukuze uthole imibuzo evamile uma unemibuzo mayelana nokubuyiselwa emuva.

• Bika noma yimiphi imiphumela emibi ehlobene nomkhiqizo wezempilo noma izikhalazo kwa-Health Canada.